Physician profile
Minhui Kim
NPI 1982220877
$5,661.31
in general payments reported to CMS, 2019-2025
14 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $405 · 2022: $501 · 2023: $3,800 · 2024: $697 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,844 · Travel and Lodging: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,843.77 |
| Travel and Lodging | $411.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,971.31 | 2023 | Da Vinci Sp, Da Vinci Surgical System |
| Allergan, INC. | $658.45 | 2021-2022 | |
| Acera Surgical, INC. | $482.25 | 2024-2025 | Restrata Wound Matrix |
| Abbvie INC. | $396.14 | 2023-2024 | |
| Inspire Medical Systems, INC. | $364.09 | 2023-2024 | Inspire |
| Stryker Corporation | $237.51 | 2022-2023 | Vsp System, Vsp Cranial, Na |
| Depuy Synthes Sales INC. | $180.97 | 2021-2023 | Trumatch |
| Kerecis Limited | $158.07 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $73.01 | 2025 | V-Loc 180 |
| Tela Bio, INC. | $41.19 | 2022 | |
| Genzyme Corporation | $32.26 | 2023 | |
| Optinose US, INC. | $23.89 | 2023 | |
| Lifenet Health | $22.93 | 2025 | Theragenesis Wound Matrix |
| Medical Device Business Services, INC. | $19.24 | 2023 | Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minhui Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.